188 related articles for article (PubMed ID: 23835051)
1. Cognitive dysfunction associated with anti-glutamic acid decarboxylase autoimmunity: a case-control study.
Takagi M; Ishigaki Y; Uno K; Sawada S; Imai J; Kaneko K; Hasegawa Y; Yamada T; Tokita A; Iseki K; Kanno S; Nishio Y; Katagiri H; Mori E
BMC Neurol; 2013 Jul; 13():76. PubMed ID: 23835051
[TBL] [Abstract][Full Text] [Related]
2. Cognitive decline in a patient with anti-glutamic acid decarboxylase autoimmunity; case report.
Takagi M; Yamasaki H; Endo K; Yamada T; Kaneko K; Oka Y; Mori E
BMC Neurol; 2011 Dec; 11():156. PubMed ID: 22188660
[TBL] [Abstract][Full Text] [Related]
3. GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes.
Castleden HA; Shields B; Bingley PJ; Williams AJ; Sampson M; Walker M; Gibson JM; McCarthy MI; Hitman GA; Levy JC; Hattersley AT; Vaidya B; Pearson ER
Diabet Med; 2006 Aug; 23(8):834-8. PubMed ID: 16911619
[TBL] [Abstract][Full Text] [Related]
4. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus.
Borg H; Fernlund P; Sundkvist G
Clin Chem; 1997 Dec; 43(12):2358-63. PubMed ID: 9439455
[TBL] [Abstract][Full Text] [Related]
5. Glutamate decarboxylase autoimmunity and growth hormone secretion in type I diabetes mellitus.
Giustina A; Desenzani P; Perini P; Bazzigaluppi E; Bodini C; Bossoni S; Poiesi C; Wehrenberg WB; Bosi E
Metabolism; 1997 Apr; 46(4):382-7. PubMed ID: 9109840
[TBL] [Abstract][Full Text] [Related]
6. Glutamic acid decarboxylase antibodies are indicators of the course, but not of the onset, of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities Study.
Vigo A; Duncan BB; Schmidt MI; Couper D; Heiss G; Pankow JS; Ballantyne CM
Braz J Med Biol Res; 2007 Jul; 40(7):933-41. PubMed ID: 17653446
[TBL] [Abstract][Full Text] [Related]
7. GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6).
Zampetti S; Capizzi M; Spoletini M; Campagna G; Leto G; Cipolloni L; Tiberti C; Bosi E; Falorni A; Buzzetti R;
J Clin Endocrinol Metab; 2012 Oct; 97(10):3759-65. PubMed ID: 22865904
[TBL] [Abstract][Full Text] [Related]
8. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
Lindholm E; Hallengren B; Agardh CD
Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
[TBL] [Abstract][Full Text] [Related]
9. Associated autoimmunity in Type 1 Diabetes and latent autoimmune diabetes of adults: The role of glutamic-acid decarboxylase autoantibodies.
Gougourelas D; Tsentidis C; Koufadaki AM; Koutsovasilis A; Gougourela E; Karanasios S; Sotiropoulos A; Bousboulas S; Karavanaki KA
Diabetes Res Clin Pract; 2021 May; 175():108847. PubMed ID: 33945840
[TBL] [Abstract][Full Text] [Related]
10. Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent state.
Oikawa Y; Tanaka H; Uchida J; Atsumi Y; Osawa M; Katsuki T; Kawai T; Shimada A
Endocr J; 2017 Feb; 64(2):163-170. PubMed ID: 27760891
[TBL] [Abstract][Full Text] [Related]
11. Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up.
Huang G; Yin M; Xiang Y; Li X; Shen W; Luo S; Lin J; Xie Z; Zheng P; Zhou Z
Diabetes Metab Res Rev; 2016 Sep; 32(6):615-22. PubMed ID: 26787598
[TBL] [Abstract][Full Text] [Related]
12. [Latent autoimmune diabetes of adult or slim type 2 diabetes mellitus?].
Calsolari MR; Rosário PW; Reis JS; Silva SC; Purisch S
Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):315-21. PubMed ID: 18438542
[TBL] [Abstract][Full Text] [Related]
13. Islet cell-associated autoantibodies in Ethiopians with diabetes mellitus.
Siraj ES; Gupta MK; Yifter H; Ahmed A; Kebede T; Reja A; Abdulkadir J
J Diabetes Complications; 2016 Aug; 30(6):1039-42. PubMed ID: 27220543
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of INS VNTR is associated with glutamic acid decarboxylase antibodies and postprandial C-peptide in patients with onset of diabetes after 35 years of age.
Matejková-Behanová M; Vanková M; Hill M; Kucera P; Cinek O; Andel M; Bendlová B
Physiol Res; 2004; 53(2):187-90. PubMed ID: 15046555
[TBL] [Abstract][Full Text] [Related]
15. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
Turner R; Stratton I; Horton V; Manley S; Zimmet P; Mackay IR; Shattock M; Bottazzo GF; Holman R
Lancet; 1997 Nov; 350(9087):1288-93. PubMed ID: 9357409
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
[TBL] [Abstract][Full Text] [Related]
17. Characterization of CD4+ T cells specific for glutamic acid decarboxylase (GAD65) and proinsulin in a patient with stiff-person syndrome but without type 1 diabetes.
Hänninen A; Soilu-Hänninen M; Hampe CS; Deptula A; Geubtner K; Ilonen J; Knip M; Reijonen H
Diabetes Metab Res Rev; 2010 May; 26(4):271-9. PubMed ID: 20503259
[TBL] [Abstract][Full Text] [Related]
18. Family history of Type 1 diabetes affects insulin secretion in patients with 'Type 2' diabetes.
Lundgren VM; Andersen MK; Isomaa B; Tuomi T
Diabet Med; 2013 May; 30(5):e163-9. PubMed ID: 23157220
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in Korea.
Kim CS; Nam JH; Nam JS; Park JS; Kang ES; Ahn CW; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
Metabolism; 2006 Aug; 55(8):1107-12. PubMed ID: 16839848
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of anti-glutamic acid decarboxylase antibody-positive fulminant type 1 diabetes.
Saito D; Oikawa Y; Mizutani G; Inoue K; Hatano M; Inoue I; Noda M; Shimada A
Endocr J; 2019 Apr; 66(4):329-336. PubMed ID: 30760658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
